AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 587 businesses audited.
Medical Devices, Pharma & Biotech BS: Erivedge (Genentech) (erivedge.com)
A high-authority, low-BS site that is legally tethered to reality by FDA regulations. Its only significant bullshit is the ‘marketing film’ of repetitive emotional taglines and the use of 16-year-old case studies to represent a modern market leader.
1. Replace the 2010 case studies with patients from the 2021-2025 IQVIA data set to eliminate temporal drift. 2. Remove the 4x repetition of the H5 tagline on the homepage to improve heading information density. 3. Add direct outbound links to ClinicalTrials.gov for the specific studies mentioned to move from ‘Trust Theatre’ to ‘Verified Proof’. 4. Standardize the disclaimer across pages to clarify where models are used versus actual trial participants.
The information density is high in substance but marred by structural fluff and stale evidence. While the body text contains specific technical protocols (e.g., pregnancy test within 7 days, 24-month breastfeeding prohibition), the H5 heading ‘Because there’s more to you than your advanced basal cell carcinoma’ is repeated four times on the homepage alone, creating a high fluff-to-heading ratio. Furthermore, while the IQVIA data is current (through August 2025), the primary patient case studies (Matt and Marsha) rely on data from November 2010, representing a significant temporal gap of over 15 years from the audit date.
A site without a coherent link graph forces AI to guess which pages matter. Reveal your real semantic graph and see how your domain is actually mapped by machine logic.
Minor semantic drift exists between the homepage’s aggressive market positioning and the sub-page’s clinical realism. The homepage H1 and hero claim Erivedge is the ‘#1 most-prescribed oral medication,’ yet the patient stories sub-page includes Marsha, a patient who experienced a ‘non-response’ to the treatment. While scientifically honest, this creates a disconnect between the hero signal of efficacy and the substance of the individual journeys provided as proof.
Identify the current state and friction diagnosis of your specific business model. Generate your Executive SEO Strategy to quantify the financial or conversion cost of strategic misalignment.
The site exhibits minor trust theatre patterns with a review_count of 2 on the ‘How It Works’ page without corresponding external proof_links_count. The patient stories are hosted internally with no links to third-party clinical validation or peer-reviewed journals in the crawled text. Additionally, the homepage uses a ‘Model is not an actual patient’ disclaimer for its primary hero image, which slightly undermines the ‘Real Patient Stories’ H2 signal.
Proof density is high regarding safety and regulatory requirements but lower regarding recent efficacy. The site provides 8+ instances of specific evidence, including FDA reporting numbers (800-FDA-1088), molecular mechanism of action details, and median treatment durations (10.2 months). The ratio of substance to fluff is approximately 4:1, which is superior for the pharma industry.
To evaluate URL identity stability and multilingual coherence, review the Yoast Identity Stability audit. View the Yoast Identity Stability Audit for a practical example of canonical alignment and language layer integrity.
The site contains standard pharmaceutical commodity language but avoids the worst cliches of service industries. Matches for ‘groundbreaking science’ and ‘life-changing therapies’ appear in the Genentech Organization schema, and the ‘Important Safety Information’ blocks follow a rigid, boilerplate regulatory template required by the FDA. The value proposition is drug-specific and cannot be copy-pasted, though the emotional tagline H5 is a common industry value-prop cliche (‘beyond the molecule’ style).
Authority is exceptionally high with zero gaps. The schema_json provides a complete Organization profile for Genentech, including a physical address in South San Francisco, a customer service contact point, and specific MedicalWebPage markup. The use of named case studies (Matt and Marsha) is grounded in clinical study parameters, although they lack individual Person schema or sameAs links to professional registries.
The ‘#1 most-prescribed’ claim is substantiated by a specific citation of IQVIA real-world data (Feb 2012–Aug 2025), which is a high-authority proof point. However, the disconnect lies in the age of the patient metrics; claiming market leadership in 2026 using case studies from 2010 suggests a lack of recent clinical substantiation in the narrative content.
Medical Devices, Pharma & Biotech BS: Erivedge (Genentech) (erivedge.com)
The site perfectly aligns with the Pharma & Biotech industry, specifically the oncology therapeutic area. It utilizes dense regulatory language, FDA-mandated safety disclosures (Boxed Warnings), and pharmacovigilance mechanisms consistent with a prescription drug platform.
Every retrieval failure begins with one root cause: the model cannot segment the page correctly. Read the Semantic HTML Technical Guide to learn how structural clarity prevents chunk collapse and embedding noise.
“The score of 20 is primarily driven by the Information Density pillar (stale 2010 data and repetitive taglines) and the Trust and Proof pillar (internal reviews without outbound verification). The site scores 0 in Identity and Authority due to its robust, verified corporate and regulatory footprint.”